Get started
JetEquities

Emergent BioSolutions Awarded 10-Year HHS Contract Valued at App

Long
Emergent Biosolutions, Inc. (NYSE:EBS)  
JetEquities  
NYSE:EBS   Emergent Biosolutions, Inc.
Beyond Technical Analysis
2
0
beyondta
EBS: Emergent BioSolutions
2019-06-03 06:30:00
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness - GlobeNewswire
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.